Dual diagnosis treatment for Coral Springs — one team, both diagnoses, together.

RECO Health sits 35 minutes east of Coral Springs via the Sawgrass Expressway and I-95 — close enough for families in Eagle Trace, Parkland Isles, and Heron Bay to reach specialist-level addiction psychiatry that most Broward outpatient options don't offer. In-house psychiatrists manage MAT (buprenorphine, naltrexone, acamprosate) and psychotropic medication together, therapists credentialed in CPT, PE, and EMDR handle the trauma work, and rTMS and intranasal esketamine are available on-site for treatment-resistant depression. One team, one shared plan, both diagnoses treated concurrently.

Coral Springs sits about 25 miles inland from RECO Health’s Delray Beach campus — a 35-minute run east on the Sawgrass Expressway and down I-95. For families in Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, and Heron Bay, that short drive opens access to something the immediate Broward market rarely offers: specialist-level addiction psychiatry paired with the coastal treatment-community network that has shaped South Florida recovery for decades. RECO’s dual diagnosis program treats substance use disorder and co-occurring psychiatric illness as one clinical problem, not two — with one team, one plan, and both diagnoses managed concurrently rather than sequentially.

Why sequential treatment fails for co-occurring disorders

The literature on this is unambiguous. Sequential care — the model that says “get sober first, then we’ll deal with the depression” — produces worse outcomes at every measurable endpoint than integrated care. The untreated diagnosis reliably destabilizes the treated one: depression that remains unaddressed during early sobriety drives the affective misery that precedes most 90-day relapses, and active substance use during a depressive episode blunts SSRI response through mechanisms that are now well characterized in the neuroimaging and pharmacokinetic literature.

SAMHSA, ASAM, and APA converged more than a decade ago on integrated treatment as the standard of care for co-occurring disorders. The clinical requirement is straightforward but operationally rare: dually trained staff, one shared treatment plan, and prescribing decisions and psychotherapy targets updated in the same weekly case conference. RECO’s dual diagnosis track is built around that requirement rather than adjacent to it.

The alternative — referring the mental health work to an outside provider while the addiction program proceeds — introduces exactly the coordination gaps that predict early dropout and readmission. Clinicians who do this work full-time see the pattern weekly.

The high-prevalence co-occurring diagnoses

Five diagnoses account for the overwhelming majority of dual diagnosis presentations: major depressive disorder, PTSD, generalized anxiety disorder, bipolar spectrum illness, and adult ADHD. RECO screens for each at intake using validated instruments — the PHQ-9 for depression, PCL-5 for PTSD, GAD-7 for anxiety, MDQ for bipolarity, and ASRS for ADHD — alongside the ASAM Criteria’s six dimensions and, where indicated, the CIWA-Ar for alcohol withdrawal and COWS for opioid withdrawal.

Each positive screen routes into a defined evidence-based pathway. Depression is treated with an SSRI or SNRI — sertraline, escitalopram, or venlafaxine as first-line — combined with cognitive behavioral therapy; treatment-resistant presentations are considered for the in-house rTMS service (typically 3,000 pulses per session at 120% of motor threshold over a six-week course) or intranasal esketamine. PTSD is treated with Cognitive Processing Therapy, Prolonged Exposure, or EMDR once the client’s window of tolerance permits trauma processing. Bipolar disorder is managed with mood stabilizer optimization — lithium, valproate, lamotrigine, or a second-generation antipsychotic such as quetiapine, aripiprazole, or olanzapine — and the antidepressant question is handled carefully to avoid induced mania.

Adult ADHD is a subtler case. In active or recent substance use, stimulant prescribing carries obvious risk; RECO’s psychiatrists frequently begin with atomoxetine or bupropion, reassess at 30 and 60 days of sustained abstinence, and reintroduce a stimulant only with structured diversion controls and scheduled urine drug monitoring.

MAT and psychotropic medication managed by one psychiatrist

Fragmented prescribing is one of the most reliable relapse pathways in the co-occurring population. A primary care physician manages the antidepressant, an outside psychiatrist manages the mood stabilizer, an MAT provider handles the buprenorphine, and no one holds the complete medication list. Interactions get missed, dosing decisions are made without the full clinical picture, and the client is left triangulating between providers who do not talk to each other.

At RECO, buprenorphine or extended-release naltrexone for opioid use disorder, naltrexone or acamprosate for alcohol use disorder, and the client’s psychotropic regimen are all managed by the same in-house addiction psychiatrist. Interactions are flagged in the shared record, contraindications are checked against the current diagnosis list (bupropion in a seizure history, lithium in renal impairment, QTc considerations for methadone or certain second-generation antipsychotics), and dosing changes are coordinated with the therapy team rather than made in isolation. When a client on buprenorphine needs sertraline titrated for a worsening depressive episode, one clinician is making both calls.

Trauma is often the through-line

For a substantial share of dual diagnosis clients, unprocessed trauma sits upstream of both the substance use and the mood disorder. Treating the substances without addressing the trauma tends to work for the length of the residential stay and fail within months of discharge, because the affect the substances were regulating remains unregulated.

RECO’s protocol screens trauma at intake with the PCL-5 and a structured clinical interview, stabilizes affect and sleep in the first two to three weeks — often with prazosin for nightmares and a short course of hydroxyzine or buspirone for daytime anxiety — and moves into evidence-based trauma processing once the window of tolerance is wide enough to hold it. Cognitive Processing Therapy, Prolonged Exposure, and EMDR are delivered by clinicians credentialed in each modality; the choice among them is made by the therapist and client together based on the trauma’s characteristics and the client’s preference. Acceptance and Commitment Therapy and DBT skills training round out the psychotherapy stack for clients whose affect regulation needs longer-arc work.

What to expect in the first two weeks

The first 72 hours are largely assessment. A board-certified addiction psychiatrist conducts the psychiatric evaluation, a licensed clinician takes the substance use and treatment history, and a nurse completes the medical intake including vital signs, physical exam, comprehensive metabolic panel, CBC, hepatic panel, and toxicology. The screening battery described above generates the working diagnosis list. If medically supervised withdrawal is indicated, it begins on-site under CIWA-Ar or COWS monitoring with the appropriate protocol — benzodiazepine taper for alcohol, buprenorphine induction for opioids.

Once withdrawal is complete or ruled out, the clinical picture clarifies enough to distinguish substance-induced psychiatric symptoms from independent primary diagnoses — a distinction with real treatment implications. Psychotherapy begins in week one with Motivational Interviewing and CBT-based relapse prevention; trauma-focused work is scheduled once affective stability supports it. Family sessions are typically introduced in week two or three when clinically appropriate.

Insurance and admissions from Coral Springs

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and most BCBS plans. Admissions runs a full benefits verification before the client arrives, so residential, PHP, and IOP authorization and any out-of-pocket estimate are known before treatment starts rather than after. For families driving in from Coral Springs, admissions can typically complete the intake in a single visit and confirm a start date within 24 to 48 hours of the initial call.

Serving residents of: Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, Heron Bay.